Retigabine N-β-D-glucuronide-d4
Retigabine N-β-D-glucuronide-d4 is the deuterium labeled Retigabine N-β-D-glucuronide[1].
Product Specifications
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Others
Solubility
10 mM in DMSO
Smiles
CCOC(NC(C=CC(NCC1=C([2H])C([2H])=C(C([2H])=C1[2H])F)=C2)=C2N[C@@H]3O[C@@H]([C@H]([C@@H]([C@H]3O)O)O)C(O)=O)=O
Molecular Formula
C22H22D4FN3O8
Molecular Weight
483.48
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
245782-AP 100 µL
EPHB3 (EPH Receptor B3, ETK2, HEK2, TYRO6) (AP) discontinued
Request Quote
View Details 233137-01 1 g
4-Ethyl-3,5-dimethyl-1H-pyrrole-2-carbaldehyde 99+.9% (HPLC)
Request Quote
View Details 233137-02 5 g
4-Ethyl-3,5-dimethyl-1H-pyrrole-2-carbaldehyde 99+.9% (HPLC)
Request Quote
View Details 233137-03 25 g
4-Ethyl-3,5-dimethyl-1H-pyrrole-2-carbaldehyde 99+.9% (HPLC)
Request Quote
View Details 